Inhibition of inner ear ornithine decarboxylase by neomycin in-vitro
dc.contributor.author | Henley, III, Charles M. | en_US |
dc.contributor.author | Gerhardt, Hans-J. | en_US |
dc.contributor.author | Schacht, Jochen | en_US |
dc.date.accessioned | 2006-04-07T19:45:27Z | |
dc.date.available | 2006-04-07T19:45:27Z | |
dc.date.issued | 1987-12 | en_US |
dc.identifier.citation | Henley, III, Charles M., Gerhardt, Hans-J., Schacht, Jochen (1987/12)."Inhibition of inner ear ornithine decarboxylase by neomycin in-vitro." Brain Research Bulletin 19(6): 695-698. <http://hdl.handle.net/2027.42/26494> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6SYT-485G62F-DR/2/ce488203105bff0b376b0d5b47259514 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/26494 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3125950&dopt=citation | en_US |
dc.description.abstract | We quantitated the activity of ornithine decarboxylase (ODC) in homogenates and subcellular fractions of inner ear tissues from the rat and guinea pig and demonstrate inhibition of cochlear ODC by the aminoglycoside neomycin. Subcellular fractionation showed the enzyme associated with the postmitochondrial supernatant fraction in each of the tissues: Specific activities of ODC, defined as [alpha]-difluoromethylornithine (DFMO)-sensitive decarboxylation of ornithine, in the supernatant fractions of combined inner ear tissues were: guinea pig=44 +/- 4 pmoles CO2 produced/hour/mg protein, and rat=133 +/- 30. In the guinea pig, supernatant fractions of the lateral wall tissues (stria vascularis and spiral ligament) had specific activities of 62 +/- 25, those of the organ of Corti (plus Vlllth nerve) 64 +/- 41. The ototoxic aminoglycoside neomycin produced a dose-dependent inhibition of ODC with half-maximal inhibition observed at 50 [mu]M drug and almost complete inhibition at 100 [mu]M. This is the first report of the presence of ODC in the inner ear and its inhibition by neomycin. Since both the ODC-inhibitors, DFMO and neomycin, can cause hearing loss in patients and experimental animals it is suggested that inhibition of ODC may be an important factor in the ototoxicity of these drugs. | en_US |
dc.format.extent | 565690 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Inhibition of inner ear ornithine decarboxylase by neomycin in-vitro | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Molecular, Cellular and Developmental Biology | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Kresge Hearing Research Institute, University of Michigan, Ann Arbor, MI 48109, USA | en_US |
dc.contributor.affiliationum | Kresge Hearing Research Institute, University of Michigan, Ann Arbor, MI 48109, USA | en_US |
dc.contributor.affiliationum | Kresge Hearing Research Institute, University of Michigan, Ann Arbor, MI 48109, USA | en_US |
dc.identifier.pmid | 3125950 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/26494/1/0000030.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0361-9230(87)90056-6 | en_US |
dc.identifier.source | Brain Research Bulletin | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.